liver
Pharma

Madrigal’s Rezdiffra storms past blockbuster milestone

Madrigal plans to launch a 2,000-subject study focused on MASH patients with clinically significant portal hypertension.
Angus Liu Nov 3, 2026 3:23pm
Resource Icon
The direct-to-patient DTP market is full of providers making bold claims But claims are not outcomes To unlock the true p

DTP – Delivering Proof Over Promise

Brought to you by Gifthealth
next step ladder climb succeed win

Amgen names internal successor as quality chief retires

Nov 3, 2026 3:21pm
roundabout

Pfizer tops Q3 estimates with strong sales and cost cuts

Nov 3, 2026 11:51am
Bayer Bill Anderson

Pharma rebound puts Bayer split debate back on the table

Nov 3, 2026 11:27am
Lonza

Lonza bets big on US growth, snaps up Merck KGaA’s CDMO business

Nov 3, 2026 9:21am
More News

Sumitomo's Gemtesa drives home overactive bladder awareness

Nov 2, 2026 4:53pm

Hansoh written up after FDA inspections

Nov 2, 2026 2:56pm

Inovio wins FDA nod for DNA-based immunotherapy in rare disease

Nov 2, 2026 10:53am

Karyopharm files Chapter 11 ahead of Ayrmid merger

Nov 2, 2026 10:46am